To receive daily emails from Breaking Christian News to your inbox CLICK HERE


SHARE THIS ARTICLE Printer friendly version of this page

Study: Abortion Drug Complications 22 Times More Common than FDA Admits

S.A. McCarthy : Apr 29, 2025  The Washington Stand

Given the results of the report, the EPPC made several recommendations for the FDA to revise its policy regarding the prescription and use of mifepristone and "reinstate the original patient safety protocols that were required when mifepristone was first approved" in 2000. At that time, prerequisites for a mifepristone prescription included three in-person physician visits, the drug could only be prescribed by a physician, could only be dispensed in a physician's office, and had to be taken in a physician's office...

[WashingtonStand.com] An explosive new study is revealing that the abortion drug is significantly more dangerous than government health agencies have previously claimed. The Ethics and Public Policy Center (EPPC) published a report Monday detailing the dangers associated with the use of the abortion drug mifepristone. The study found that, although the US Food and Drug Administration (FDA) claims that less than half a percent of women experience serious complications, the actual rate of damage done by the drug is significantly higher. (Image credit: Robin Marty-Flickr-CC BY 2.0)

Touted as the "largest-known study of the abortion pill," the EPPC report examined data from an insurance database, covering 865,727 prescribed mifepristone abortions committed between 2017 and 2023. Here are some of the study's most important findings.

More than 1 in 10 Women Experience Complications from Mifepristone

According to the EPPC's report, 10.93% of women who used the abortion drug mifepristone experienced serious complications within 45 days as a result. Complications included sepsis (0.10% of cases), infection (1.34%), transfusion (0.15%), hemorrhage (3.31%), abortion-related hospitalization (0.66%), abortion-related emergency room visit (4.73%), ectopic pregnancy (0.35%), unspecified other abortion-specific complications (5.68%), and other life-threatening adverse events (0.22%), including cardiac and pulmonary events, thrombosis, anaphylaxis, and the necessity of surgery. In nearly 3% of instances, use of mifepristone to commit abortion was followed by surgical abortion because the drug failed.

EPPC's report noted, "Simply stated, mifepristone, as used in real-world conditions, is not 'safe and effective.'"

The FDA's Research on Mifepristone Is Inadequate

The EPPC's report finds that complications arising from mifepristone are at least 22 times more common than the 0.5% of cases touted by the FDA. The new report is, according to EPPC, "the most comprehensive study of chemical abortion safety ever conducted in the US." It relies on data collected from 28 times more mifepristone abortions than the FDA's research does and, further, is more recent and more accurate to real-world circumstances. The EPPC noted that the FDA relies "entirely on data from more than a decade ago" from "a prescreened group of generally healthy women recruited into various clinical trials conducted at different times around the world."

The cases examined by the organization "are broadly representative of the women who obtain mifepristone abortions in the US" and "receive (or fail to receive) pre- and post-abortion healthcare of the real-world quality that prevails in the America today, not the carefully controlled regimen of care that ordinarily prevails in a clinical trial."

The FDA Needs to Revise Its Standards for Mifepristone Prescription

Given the results of the report, the EPPC made several recommendations for the FDA to revise its policy regarding the prescription and use of mifepristone and "reinstate the original patient safety protocols that were required when mifepristone was first approved" in 2000. At that time, prerequisites for a mifepristone prescription included three in-person physician visits, the drug could only be prescribed by a physician, could only be dispensed in a physician's office, and had to be taken in a physician's office. There were also requirements for a follow-up physician visit and for adverse event reporting.

In 2016, under then-President Barack Obama, almost all of those safeguards were removed, with only one in-person physician visit required and the drug still being dispensed in the physician's office. In 2023, the Biden administration eliminated even those two remaining safeguards. The EPPC suggested that reinstating the original FDA guidelines from 2000 "will likely reduce the harms to women and permit better monitoring to determine whether this drug should remain on the market." Subscribe for free to Breaking Christian News here

S.A. McCarthyserves as a news writer at The Washington Stand.







SHARE THIS ARTICLE Printer friendly version of this page

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Other Recent Articles from Breaking Christian News

60,000 Christians Rally for Jesus in One of the World's Most Secular Countries

New Research: The Big Questions on Teens' Minds Today

'Help Me!': Botched Euthanasia Exposes the Horrific Reality Behind 'Medical Aid in Dying'

A New Study Just Confirmed the Left's Worst-Kept Secret

The European Mind Meets America, and Falls in Love

WATCH: Mauricio Ruffy Quotes John 3:16 After Defeating Michael Chandler at UFC Freedom 250: 'Jesus Saved My Life... Give Your Life to Jesus'

A Patriotic, and Historic UFC Night at the White House

President Trump on His Birthday, Announces Deal With Iran Completed: 'Will Bring Peace and Security to the Whole Region'

Americans Split On Pastors Using AI, Skeptical It Can Help With Understanding the Bible

Daughters of the American Revolution to Vote on Definition of 'Woman' amid Criticism of Transgender Policy

FYI: These 568 Companies Are Paying to Trans Kids. A Nationwide Campaign Demands They Stop

'They Paid Me to Vote': Homeless Residents Make Explosive Claims after Spencer Pratt's Loss [Video]

America Becomes India's Top Gas Supplier amid Strait of Hormuz Conflict

Netanyahu: 'Iran Will Not Have Nuclear Weapons'

'Fauci, Biden Admin Lied to American People': DNI Gabbard Reveals Evidence of US Taxpayer-Funded Global Biolab Program

Human Trafficking Update: Feds Identify 15,500 Sponsors of Multiple Unaccompanied Kids

Ainsley Earhardt Celebrates America; Reveals Supernatural Experience That Strengthened Her Faith [Video]

Melania Trump Launches First-of-Its-Kind Foster Youth Accounts to Give Children Asset Ownership

Changing Tide: Record-low 38% of Americans Support 'Gender Transitions' - Gallup Poll

4 States Offering Pride Month Alternatives That Celebrate Family



Search the Articles Archives

Keyword:  
Author:  
Words Posted On:  
Day Month Year



Subscribe to
Breaking Christian News


Follow BCN on Twitter
Are You Praying for Our Government Leaders?
BCN Staff

Steve Shultz
Steve Shultz, Managing Editor
Founder and Owner


Aimee Herd
Aimee Herd, Editor


BCN Plus
Are You Praying for President Trump?
 
 

All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.


Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved


Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.

editor@breakingchristiannews.com